UK markets closed

InVivo Therapeutics Holdings Corp (04I.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.3260-0.0180 (-5.23%)
At close: 08:02AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,077
5,226
4,381
3,939
5,602
Selling general and administrative
5,779
5,424
5,519
5,158
5,895
Total operating expenses
9,856
10,650
9,900
9,097
11,497
Operating income or loss
-9,856
-10,650
-9,900
-9,097
-11,497
Total other income/expenses net
1
9
2
4
-587
Income before tax
-9,327
-10,490
-9,895
-9,074
-11,830
Income from continuing operations
-9,327
-10,490
-9,895
-9,074
-11,830
Net income
-9,327
-10,490
-9,895
-9,074
-11,830
Net income available to common shareholders
-9,327
-10,490
-9,895
-9,074
-11,830
Basic EPS
-3.28
-6.83
-7.48
-32.75
-882.00
Diluted EPS
-3.28
-6.83
-7.48
-32.75
-882.00
Basic average shares
2,738
1,536
1,324
276.107
13.413
Diluted average shares
2,738
1,536
1,324
276.107
13.413